
Peer-reviewed science, clinical education, and longevity insights authored by XELGEN Science Team — Original Article.
Biological age reflects the cumulative effects of genetics, lifestyle, and environment on the body's systems — and it can differ dramatically from chronological age.
Two people born the same year can have biological ages 20 years apart. The molecular mechanisms behind differential aging rates and what this means for clinical practice.
DNA methylation patterns change systematically across the genome as humans age. How epigenetic clocks use these patterns to estimate biological age with clinical-grade accuracy.
A comprehensive guide to the four major epigenetic aging clocks — how they work, what they predict, and how to choose the right one for your clinical application.
Among all molecular biomarkers of aging, DNA methylation stands out for its precision, reproducibility, and clinical applicability. A scientific comparison of the leading aging biomarker classes.
Stem cell function declines with age due to epigenetic drift — systematic changes in DNA methylation that alter self-renewal, differentiation, and regenerative capacity.
Senescent cells accumulate with age and release inflammatory SASP factors that damage surrounding tissues — driving cardiovascular disease, neurodegeneration, and metabolic disorders.
Diet, sleep, stress, and environmental exposures leave measurable epigenetic signatures. How lifestyle factors accelerate or decelerate biological aging and what this means for longevity medicine.
The Fitzgerald trial and TRIIM study suggest epigenetic age can shift in response to targeted interventions. A critical review of the evidence and clinical implications.
Biological age is not a fixed score — it fluctuates in response to illness, stress, and recovery. Understanding its dynamic nature is essential for longitudinal monitoring.
Machine learning and multi-omics integration are transforming how we predict biological age — enabling personalized aging trajectories and AI-driven longevity protocols.
Multi-omics approaches combine genomic, epigenetic, proteomic, and metabolomic data to build comprehensive models of biological aging beyond what any single layer can reveal.
Japan's conditional approval pathway and certified review committee system represent a globally influential model for balancing clinical innovation with patient safety.
Standardized biomarker datasets are essential for reproducible research, cross-study validation, and regulatory acceptance — the foundation of evidence-based longevity medicine.
Longevity medicine is evolving toward individualized, biomarker-driven protocols that measure biological aging at the molecular level and evaluate interventions with scientific rigor.
Epigenetic aging acceleration is associated with cardiovascular disease, metabolic syndrome, and all-cause mortality. How biological age biomarkers complement traditional risk assessment tools.
Vascular aging is not simply a function of time — it is a function of biological aging rate. How epigenetic biomarkers capture cardiovascular aging processes at the molecular level.
Longitudinal biological age monitoring converts a longevity program from a subjective wellness experience into a measurable, data-driven clinical protocol.
Precision longevity medicine is emerging as a new clinical paradigm — where biomarker-driven insights support personalized health optimization before disease develops.
© 2026 XELGEN. All articles authored by XELGEN Science Team. For physician and research use only.